CatalystFDA/Bio

MERCK'S CHOLESTEROL PILL LIPFENDRA GETS U.S. FDA APPROVAL - CNBC

FDA approval for Merck's new cholesterol drug Lipfendra signals major regulatory catalyst.

What changed

FDA approval for Merck's new cholesterol drug Lipfendra signals major regulatory catalyst.

Why it matters

FDA approval for Merck's new cholesterol drug Lipfendra signals major regulatory catalyst. — impact context not separately stored; see What changed.

Sources